Journal
BRITISH JOURNAL OF CANCER
Volume 94, Issue 6, Pages 842-853Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6603030
Keywords
prostate cancer; arachidonic acid; metastasis; bone marrow; Omega 6; Omega 3
Categories
Ask authors/readers for more resources
Epidemiological studies have shown not only a relationship between the intake of dietary lipids and an increased risk of developing metastatic prostate cancer, but also the type of lipid intake that influences the risk of metastatic prostate cancer. The Omega- 6 polyunsaturated fatty acid, Arachidonic acid, has been shown to enhance the proliferation of malignant prostate epithelial cells and increase the risk of advanced prostate cancer. However, its role in potentiating the migration of cancer cells is unknown. Here we show that arachidonic acid at concentrations <= 5 mu M is a potent stimulator of malignant epithelial cellular invasion, which is able to restore invasion toward hydrocortisone- deprived adipocyte- free human bone marrow stroma completely. This observed invasion is mediated by the arachidonic acid metabolite prostaglandin E-2 and is inhibited by the Omega- 3 poly- unsaturated fatty acids eicosapentaenoic acid and docosahexaenoic acid at a ratio of 1 : 2 Omega- 3 : Omega- 6, and by the COX- 2 inhibitor NS- 398. These results identify a mechanism by which arachidonic acid may potentiate the risk of metastatic migration and secondary implantation in vivo, a risk which can be reduced with the uptake of Omega- 3 poly- unsaturated fatty acids.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available